Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Insights
    3. Alerts
    4. EPA attempts to stop pharmaceuticals from going down the drainAlerts

    Alert / Environment Law Alert

    EPA attempts to stop pharmaceuticals from going down the drain

    June 19, 2019

    Share

    By Alison Torbitt and Dana Stanton

    Nationwide, 80% of lakes, rivers and streams now contain low levels of pharmaceuticals. Chronic exposure to low levels of medications in the environment, even expired medications, harms the fertility of fish and other aquatic animals. Most current municipal wastewater treatment technology cannot intercept drugs when they enter the wastewater stream. For these reasons, the EPA has finalized a new rule prohibiting health-care facilities from flushing hazardous waste pharmaceuticals down the drain.

    EPA’s rule, 40 CFR Part 266, Subpart P, entitled, “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” will prevent the flushing of 1,644 to 2,300 tons of hazardous waste pharmaceuticals annually by banning the disposal of hazardous waste pharmaceuticals down the sink or toilet.

    In addition, health-care facilities will be allowed to manage hazardous waste pharmaceuticals under the Subpart P regulations—which are tailored to the needs of the health-care industry—rather than comply with the general Resource and Conservation Recovery Act (RCRA) requirements—which are a poor fit for many health-care facilities. The full text of the rule is available here.

    Health-care facilities and reverse distributors that generate and manage hazardous waste pharmaceuticals will be subject to Subpart P. “Health-care facility” is broadly defined to include hospitals, health clinics, physician’s offices, long-term care facilities, optical and dental providers, ambulatory services, veterinary clinics and hospitals and pharmacies. “Reverse distributors” are entities that help health-care facilities calculate and receive credit from pharmaceutical manufacturers when health-care facilities have unused pharmaceuticals they no longer need. The rule does not apply to pharmaceutical manufacturers (unless they act as reverse distributors), production facilities or other generators of hazardous waste pharmaceuticals.

    EPA’s definition of “pharmaceutical” includes prescription and over-the-counter drugs, dietary supplements, homeopathic drugs, pharmaceuticals remaining in non-empty containers and clean-up material from spills of pharmaceuticals. In contrast, dental amalgam, sharps and medical waste are not considered “pharmaceuticals.”

    Not all pharmaceuticals will constitute “hazardous waste pharmaceuticals.” A pharmaceutical is considered a “hazardous waste” if it is a “solid waste” (for example, it is discarded or abandoned), and (i) it exhibits one or more hazardous characteristics (ignitability, corrosivity, reactivity and toxicity), or (ii) is listed by EPA as a hazardous waste at 40 CFR § 261.33.

    Importantly, pharmaceuticals are not considered “solid waste” if they can be legitimately used or re-used (for example, lawfully donated or redistributed for their intended purpose), or reclaimed.

    Health-care facilities will be required to manage their hazardous waste pharmaceuticals in accordance with Subpart P (40 CFR § 266.500 et seq.), instead of the standard, more complicated RCRA regulations under 40 CFR Part 262. Under the new paradigm, a health-care facility will not be considered a large quantity generator (with all the attendant, onerous requirements), simply by generating more than one (1) kilogram of acutely hazardous waste pharmaceuticals per month. Health-care facilities will not be subject to satellite accumulation area regulations, which are a poor fit for health-care facilities, and will be able to accumulate hazardous waste pharmaceuticals on site without a RCRA permit for up to 365 days. Finally, health-care facilities will not need to specify hazardous waste codes on manifests. Health-care facilities will need to comply with basic training requirements for personnel.

    In addition, under the new rule, over-the-counter nicotine replacement therapies, such as nicotine patches, gums and lozenges, will no longer be considered hazardous waste when discarded. Therefore, these wastes may be discarded as non-hazardous waste. This will result in cost savings with respect to managing nicotine wastes.

    The prohibition on sewer disposal automatically takes effect in all states and territories on August 21, 2019. Subpart P goes into effect in Iowa and Alaska on August 21, 2019, and will go into effect for the remainder of the states when adopted by each state—all are required to adopt Subpart P by July 1, 2021 (or July 1, 2022, if a statutory amendment is required). Since it is less stringent than the current regulation, the nicotine waste aspect of the rule is not required to be adopted by the states, and health-care facilities cannot use the nicotine waste exemption unless or until it is adopted by their state.

    Practices

    EnvironmentalLife Sciences & Healthcare Compliance and InvestigationsHealthcareLife SciencesWater & Wastewater Management

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      EPA announces new strategy to address PFAS in federally-issued wastewater permits

      Dec 11, 2020
    • Press Release

      Nixon Peabody’s San Francisco office grows with addition of veteran environmental counsel

      Oct 13, 2020

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL